Menu
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow-15.24 M USD-12.49 M USD-6.56 M USD-3.73 M USD-3.77 M USD-3.50 M USD-3.90 M USD-4.89 M USD-5.90 M USD-5.31 M USD-4.57 M USD-3.36 M USD
Depreciation & Amortization42000 USD36000 USD13000 USD23000 USD32000 USD32000 USD50590 USD58789 USD67878 USD59584 USD44891 USD34683 USD
Stock-Based Compensation211000 USD173000 USD281000 USD439000 USD223000 USD22000 USD356218 USD705248 USD2.67 M USD70247 USD18013 USD50380 USD
Capital Expenditures96000 USD104000 USD1000 USD5000 USD53000 USD23432 USD5371 USD19467 USD76455 USD143736 USD63455 USD
Cash Flow from Investing-96000 USD-104000 USD1000 USD-1000 USD-53000 USD-23432 USD-5371 USD-19467 USD-76455 USD-203167 USD-91513 USD
Cash Flow from Financing17.04 M USD13.74 M USD8.73 M USD13.01 M USD4.20 M USD4.96 M USD5.75 M USD4.94 M USD-460863 USD6.97 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow-15.34 M USD-12.59 M USD-3.73 M USD-3.77 M USD-3.55 M USD-3.92 M USD-4.90 M USD-5.91 M USD-5.39 M USD-4.71 M USD-3.43 M USD

Glucotrack Inc. is a company dedicated to developing non-invasive glucose monitoring technology. The core purpose of the company is to provide an alternative method for individuals with diabetes to track their blood glucose levels without the need for frequent finger-prick tests. This innovation primarily serves the healthcare and biotechnology sectors, offering a user-friendly solution that aims to improve patient comfort and compliance. The Glucotrack device is designed to measure glucose levels using several physiological parameters detected via an ear clip, conveying real-time data that can be crucial for metabolic management. Its focus on non-invasive technology positions it as a potential game-changer in the realm of diabetic care, especially considering the global prevalence of diabetes. In the broader market context, Glucotrack Inc. represents a significant development within the medtech industry, with its efforts reflecting an ongoing trend towards more patient-centered, convenient healthcare solutions. Its contribution lies not only in its innovative approach but also in its potential to reduce the physical and psychological barriers associated with traditional glucose monitoring methods.